Cambridge Financial Group (Arizona)’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.19M Buy
4,675
+26
+0.6% +$6.06K 0.37% 54
2026
Q1
$1.14M Sell
4,649
-634
-12% -$148K 0.38% 50
2025
Q4
$827K Buy
5,283
+727
+16% +$144K 0.29% 68
2025
Q3
$845K Buy
4,556
+232
+5% +$39.7K 0.27% 71
2025
Q2
$660K Sell
4,324
-254
-6% -$39K 0.25% 67
2025
Q1
$759K Buy
4,578
+67
+1% +$10.5K 0.32% 60
2024
Q4
$652K Sell
4,511
-44
-1% -$6.82K 0.28% 62
2024
Q3
$738K Sell
4,555
-826
-15% -$132K 0.31% 63
2024
Q2
$786K Sell
5,381
-81
-1% -$12K 0.36% 59
2024
Q1
$864K Sell
5,462
-52
-0.9% -$8.28K 0.41% 52
2023
Q4
$864K Buy
+5,514
New +$846K 0.45% 48

Other funds holding JNJ

Cambridge Financial Group (Arizona)'s JNJ Position: Q2 2026 in Review

Cambridge Financial Group (Arizona) increased its Johnson & Johnson (JNJ) stake by 0.56% in Q2 2026, buying an estimated $6.06K and bringing the position to 4,675 shares worth $1.19M. The position accounts for 0.37% of the portfolio, ranked #54.

Cambridge Financial Group (Arizona) first reported a position in JNJ in Q4 2023 and has held it in 11 quarters since. 1,657 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Cambridge Financial Group (Arizona) held 4,675 shares of Johnson & Johnson worth $1.19M as of Q2 2026.
  • Cambridge Financial Group (Arizona) bought 26 Johnson & Johnson shares in Q2 2026, an estimated $6.06K.
  • Johnson & Johnson made up 0.37% of Cambridge Financial Group (Arizona)'s portfolio in Q2 2026, its #54 holding.
  • Cambridge Financial Group (Arizona) first reported a position in Johnson & Johnson in Q4 2023 and has held it in 11 quarters since.
  • 1,657 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Cambridge Financial Group (Arizona)'s 13F filing for Q2 2026, filed 14 Jul 2026.